FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W172587044> ?p ?o ?g. }

• W172587044 endingPage "443" @default.
• W172587044 startingPage "439" @default.
• W172587044 abstract "Borderline personality disorder (BPD) is associated with several symptoms, including impulsivity, aggression, and intense unstable affect, which can be targeted with anticonvulsant agents. Divalproex extended-release (ER) is used widely in clinical practice, which leads to the question of its efficacy and tolerability in treating BPD.This study assessed the efficacy and tolerability of divalproex ER in 20 adult outpatients with Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition BPD via a 12-week open-label trial. Primary outcome measures included the Clinical Global Impression-Improvement (CGI-I) scale and the Global Assessment Scale. Secondary outcome measures assessed aggression (Aggression Questionnaire, Overt Aggression Scale-Modified); affective disturbance (Affective Intensity Measure, Affective Lability Scale); dissociation (Dissociative Experiences Scale); and general psychopathology (Symptom-Checklist 90-Revised).Thirteen subjects were male and seven were female with a mean age of 37.0+/-11.3 years. Treatment was associated with statistically significant improvement on the CGI-I, the Global Assessment Scale, the Overt Aggression Scale-Modified irritability subscale, and the Aggression Questionnaire. A trend toward significant improvement was observed on the Affective Intensity Measure. Seven out of 10 completers (70%) were treatment responders, with an endpoint CGI-I of 2 (much improved) or 1 (very much improved). There was no significant decline in affective lability or in dissociation. One participant discontinued treatment due to adverse events.These findings support that divalproex ER is an efficacious and well-tolerated pharmacologic agent for BPD, with the additional advantage of single daily dosing at bedtime. Placebo-controlled trials are needed for replication." @default.
• W172587044 created "2016-06-24" @default.
• W172587044 creator A5012058151 @default.
• W172587044 creator A5012603245 @default.
• W172587044 creator A5025914671 @default.
• W172587044 creator A5089417659 @default.
• W172587044 creator A5091481616 @default.
• W172587044 date "2007-06-01" @default.
• W172587044 modified "2023-10-01" @default.
• W172587044 title "An Open-Label Trial of Divalproex Extended-Release in the Treatment of Borderline Personality Disorder" @default.
• W172587044 cites W1758155888 @default.
• W172587044 cites W2001732540 @default.
• W172587044 cites W2002389556 @default.
• W172587044 cites W2005291072 @default.
• W172587044 cites W2007351583 @default.
• W172587044 cites W2015030946 @default.
• W172587044 cites W2030750889 @default.
• W172587044 cites W2043784143 @default.
• W172587044 cites W2119226169 @default.
• W172587044 cites W2121811331 @default.
• W172587044 cites W2140608240 @default.
• W172587044 cites W4292810003 @default.
• W172587044 doi "https://doi.org/10.1017/s1092852900015315" @default.
• W172587044 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17545954" @default.
• W172587044 hasPublicationYear "2007" @default.
• W172587044 type Work @default.
• W172587044 sameAs 172587044 @default.
• W172587044 citedByCount "15" @default.
• W172587044 countsByYear W1725870442013 @default.
• W172587044 countsByYear W1725870442018 @default.
• W172587044 countsByYear W1725870442020 @default.
• W172587044 countsByYear W1725870442021 @default.
• W172587044 countsByYear W1725870442022 @default.
• W172587044 crossrefType "journal-article" @default.
• W172587044 hasAuthorship W172587044A5012058151 @default.
• W172587044 hasAuthorship W172587044A5012603245 @default.
• W172587044 hasAuthorship W172587044A5025914671 @default.
• W172587044 hasAuthorship W172587044A5089417659 @default.
• W172587044 hasAuthorship W172587044A5091481616 @default.
• W172587044 hasConcept C118552586 @default.
• W172587044 hasConcept C123273963 @default.
• W172587044 hasConcept C126322002 @default.
• W172587044 hasConcept C138496976 @default.
• W172587044 hasConcept C142724271 @default.
• W172587044 hasConcept C15744967 @default.
• W172587044 hasConcept C197934379 @default.
• W172587044 hasConcept C204787440 @default.
• W172587044 hasConcept C27081682 @default.
• W172587044 hasConcept C2776000289 @default.
• W172587044 hasConcept C2776174506 @default.
• W172587044 hasConcept C2776809841 @default.
• W172587044 hasConcept C2778375690 @default.
• W172587044 hasConcept C2779448149 @default.
• W172587044 hasConcept C2780319597 @default.
• W172587044 hasConcept C2780600973 @default.
• W172587044 hasConcept C2780733359 @default.
• W172587044 hasConcept C2780820931 @default.
• W172587044 hasConcept C2908949014 @default.
• W172587044 hasConcept C558461103 @default.
• W172587044 hasConcept C70410870 @default.
• W172587044 hasConcept C71924100 @default.
• W172587044 hasConcept C83849319 @default.
• W172587044 hasConceptScore W172587044C118552586 @default.
• W172587044 hasConceptScore W172587044C123273963 @default.
• W172587044 hasConceptScore W172587044C126322002 @default.
• W172587044 hasConceptScore W172587044C138496976 @default.
• W172587044 hasConceptScore W172587044C142724271 @default.
• W172587044 hasConceptScore W172587044C15744967 @default.
• W172587044 hasConceptScore W172587044C197934379 @default.
• W172587044 hasConceptScore W172587044C204787440 @default.
• W172587044 hasConceptScore W172587044C27081682 @default.
• W172587044 hasConceptScore W172587044C2776000289 @default.
• W172587044 hasConceptScore W172587044C2776174506 @default.
• W172587044 hasConceptScore W172587044C2776809841 @default.
• W172587044 hasConceptScore W172587044C2778375690 @default.
• W172587044 hasConceptScore W172587044C2779448149 @default.
• W172587044 hasConceptScore W172587044C2780319597 @default.
• W172587044 hasConceptScore W172587044C2780600973 @default.
• W172587044 hasConceptScore W172587044C2780733359 @default.
• W172587044 hasConceptScore W172587044C2780820931 @default.
• W172587044 hasConceptScore W172587044C2908949014 @default.
• W172587044 hasConceptScore W172587044C558461103 @default.
• W172587044 hasConceptScore W172587044C70410870 @default.
• W172587044 hasConceptScore W172587044C71924100 @default.
• W172587044 hasConceptScore W172587044C83849319 @default.
• W172587044 hasIssue "6" @default.
• W172587044 hasLocation W1725870441 @default.
• W172587044 hasLocation W1725870442 @default.
• W172587044 hasOpenAccess W172587044 @default.
• W172587044 hasPrimaryLocation W1725870441 @default.
• W172587044 hasRelatedWork W2009357282 @default.
• W172587044 hasRelatedWork W2037990712 @default.
• W172587044 hasRelatedWork W2056117094 @default.
• W172587044 hasRelatedWork W2075811870 @default.
• W172587044 hasRelatedWork W2090260603 @default.
• W172587044 hasRelatedWork W2128439451 @default.
• W172587044 hasRelatedWork W2601183182 @default.
• W172587044 hasRelatedWork W4247255451 @default.

• next